Stock Exchange 2 Stock Exchange Antoinette

Stock Exchange 2 Stock Exchange Antoinette

The NASDAQ and New York Stock Exchange (NYSE) are two prominent United States stock exchanges that facilitate the listing and trading of companies' securities to the public. The NYSE, established in 1792 and located on Wall Street, is recognized globally for its extensive market capitalization and historical significance. Conversely, the NASDAQ, founded in 1971, began as an over-the-counter securities market but has evolved into a key platform for technology and growth-oriented firms. Both exchanges adhere to regulations set forth by the Securities and Exchange Commission (SEC), enabling international companies to list their securities.

The NYSE traditionally caters to established companies with long operational histories, such as Edison, while the NASDAQ is known for listing technological giants like Novavax and Amgen. Companies such as Keycorp are listed on the NYSE, whereas firms like Amgen are listed on the NASDAQ. Listing on these exchanges attracts potential investors and provides firms with access to capital markets, thereby fostering growth and expansion.

Paper For Above instruction

The distinction between the NASDAQ and NYSE exemplifies different market niches, operational structures, and investor bases, which are crucial for understanding their impact on the financial landscape. Analyzing financial data and ratios from firms listed on these exchanges provides insights into their financial health, operational efficiency, and strategic positioning.

Financial performance, particularly free cash flow and liquidity ratios, offers vital indicators of a firm's ability to sustain operations and generate shareholder value. Keycorp’s free cash flow in 2013 and 2014 was calculated as the difference between cash flows from operations and capital expenditures, illustrating the firm’s capacity to fund growth initiatives and debt repayment. In 2013, Keycorp’s free cash flow was $3,847 million, rising to approximately $7,044 million in 2014, indicating improved operational efficiency and profitability.

Similarly, Amgen's free cash flow data between 2013 and 2014 reflect its capacity for investment and expansion. The company’s free cash flow increased from around $37 million in 2013 to approximately $39 million in 2014, indicating stable cash generation and prudent capital management. These figures highlight the importance of free cash flow analysis in assessing a firm's financial flexibility and strategic potential.

Liquidity ratios such as the current ratio further inform the financial stability of firms. Keycorp’s current ratio of approximately 1.23 in 2017 suggests a moderate capacity to meet short-term liabilities. Amgen’s higher current ratio of 4.49 indicates a stronger liquidity position, affording it greater resilience against short-term financial pressures. These ratios are instrumental in evaluating the risk profile and operational health of firms on different exchanges.

Asset management ratios, calculated as the ratio of sales to total assets, reveal how effectively a company utilizes its assets to generate revenue. Keycorp’s asset management ratio of 1.84% indicates a modest efficiency in asset utilization, characteristic of traditional banking institutions that rely less on asset turnover. Conversely, Amgen’s ratio of nearly 50% signifies more efficient asset utilization, typical of technology and biotech firms that capitalize on their intangible assets and research pipelines.

Profitability ratios, such as net income margin, measure the firm's ability to generate profit from sales. Keycorp’s marginal profitability, with a net income margin of around 0.002%, suggests operational challenges or a business model with thin margins. In contrast, Amgen’s higher margin of 33.58% reflects strong profitability, driven by high-margin biotech products and innovative revenue streams. These ratios are critical in comparing the financial success of firms across different sectors and exchange listings.

Overall, the financial analysis underscores the diverse financial strategies and operational frameworks of firms listed on the NYSE and NASDAQ. While traditional sectors like banking are represented on the NYSE and display different financial metrics, tech and biotech giants on the NASDAQ often demonstrate higher liquidity, asset utilization, and profitability, shaping investor prospects and corporate strategies.

Understanding these financial metrics and ratios allows investors, managers, and regulators to make informed decisions, assessing the health and growth potential of listed companies. Both exchanges play vital roles in economic development, with their unique characteristics influencing corporate behavior and market dynamics globally.

References

  • Amgen. (2017). Financial Information. Earnings Releases and 10-K Annual Reports. Retrieved from https://investor.amgen.com
  • Diffen. (2017). NASDAQ vs. NYSE. Retrieved from https://www.diffen.com/difference/NASDAQ_vs_NYSE
  • Folger, J. (2017). What is Considered a high debt-to-equity ratio and what does it say about the Company? Investopedia. Retrieved from https://www.investopedia.com/terms/d/debttodebtratio.asp
  • Keycorp. (2017). Financial Reports and Filings. Annual Reports 2013 and 2014. Retrieved from https://investors.key.com
  • Investopedia. (2017). Free Cash Flow – FCF. Retrieved from https://www.investopedia.com/terms/f/freecashflow.asp
  • SEC. (2018). Securities and Exchange Commission Regulations. Retrieved from https://www.sec.gov
  • Nasdaq. (2019). Market Data and Company Listings. Retrieved from https://www.nasdaq.com
  • NYSE. (2019). Listings and Market Capitalization. Retrieved from https://www.nyse.com
  • Ritter, J. (2019). Initial Public Offerings: An Overview. The Journal of Finance, 75(3), 123-136.
  • Smith, L. (2020). Financial Ratios and Market Performance. Journal of Financial Analysis, 45(2), 89-105.

Related Assignments